Immunohistochemical Staining for Transforming Growth Factor β1 Associates with Disease Progression in Human Breast Cancer
SM Gorsch, VA Memoli, TA Stukel, LI Gold, BA Arrick - Cancer research, 1992 - AACR
SM Gorsch, VA Memoli, TA Stukel, LI Gold, BA Arrick
Cancer research, 1992•AACRThe transforming growth factor β s (TGF-β) comprise a family of M r 25,000 pluripotent
growth factors which have been implicated in the development and progression of human
breast cancer. Conflicting data suggest that TGF-β has the potential to either inhibit or
promote the progression of mammary neoplasia. We therefore examined a pathological
library of malignant breast biopsy specimens to determine the prevalance and distribution of
immunoreactivity with antibodies specific for the three mammalian isoforms of TGF-β (β 1, β …
growth factors which have been implicated in the development and progression of human
breast cancer. Conflicting data suggest that TGF-β has the potential to either inhibit or
promote the progression of mammary neoplasia. We therefore examined a pathological
library of malignant breast biopsy specimens to determine the prevalance and distribution of
immunoreactivity with antibodies specific for the three mammalian isoforms of TGF-β (β 1, β …
Abstract
The transforming growth factor βs (TGF-β) comprise a family of Mr 25,000 pluripotent growth factors which have been implicated in the development and progression of human breast cancer. Conflicting data suggest that TGF-β has the potential to either inhibit or promote the progression of mammary neoplasia. We therefore examined a pathological library of malignant breast biopsy specimens to determine the prevalance and distribution of immunoreactivity with antibodies specific for the three mammalian isoforms of TGF-β (β1, β2, and β3). We found that intense staining for TGF-β1 was positively associated with rate of disease progression, and that this was independent of age, stage, nodal status, or estrogen receptor status (P = 0.009).
AACR